Quarterly report pursuant to Section 13 or 15(d)

11. Segment Information (Tables)

v3.7.0.1
11. Segment Information (Tables)
3 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Segment information
    Three Months Ended March 31,  
    2017     2016  
Net revenues - External                
Clinical Laboratory Operations   $ 767,010     $ 1,465,137  
Supportive Software Solutions     236,945       230,026  
Decision Support and Informatics     172,158       183,650  
    $ 1,176,113     $ 1,878,813  
Net revenues - Intersegment                
Supportive Software Solutions   $ 78,326     $ 296,348  
    $ 78,326     $ 296,348  
(Loss) income from operations                
Clinical Laboratory Operations   $ (1,341,998 )   $ (2,650,540 )
Supportive Software Solutions     (718,546 )     (1,313,313 )
Decision Support and Informatics     (301,001 )     (881,566 )
Hospital Operations     (467,316 )      
Corporate     (1,804,517 )     (1,952,437 )
Eliminations     7,851       33,660  
    $ (4,625,527 )   $ (6,764,196 )
Depreciation and amortization                
Clinical Laboratory Operations   $ 434,468     $ 581,101  
Supportive Software Solutions     157,563       164,428  
Decision Support and Informatics     8,453       14,527  
Corporate     312       875  
Eliminations     (7,851 )     (33,661 )
    $ 592,945     $ 727,270  
Capital expenditures                
Clinical Laboratory Operations   $     $ 16,885  
Supportive Software Solutions           2,117  
Hospital Operations     1,090,922        
    $ 1,090,922     $ 19,002  

 

    March 31, 2017     December 31, 2016  
Total assets                
Clinical Laboratory Operations   $ 3,568,569     $ 4,081,136  
Supportive Software Solutions     1,870,578       2,602,428  
Decision Support and Informatics     246,930       379,652  
Hospital Operations     1,342,804        
Corporate     3,839,108       2,130,191  
Eliminations     (2,786,333 )     (2,711,014 )
    $ 8,081,656     $ 6,482,393